Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
Asian Pacific Journal of Cancer Prevention : APJCP|October 3, 2013
Pyogenic liver abscess as a warning sign for primary liver cancer: a nationwide population-based studyWen-Kuan Huang, Yung-Chang Lin, Meng-Jiun Chiou, et al.Japanese Journal of Clinical Oncology|June 29, 2006
Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genesWen-Chi Chou, Shiu-Feng Huang, Kun-Yang Yeh, et al.New Biotechnology|September 28, 2015
Development of a magnetic bead-based method for the collection of circulating extracellular vesiclesChun-Liang Shih, Kowit-Yu Chong, Shih-Che Hsu, et al.Cancer Management and Research|December 10, 2019
Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian MelanomaJohn Wen-Cheng Chang, Yen-Lin Huang, Yao-Yu Chang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2024
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerJin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, et al.Thoracic Cancer|May 28, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patientsJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.Thoracic Cancer|November 25, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from TaiwanJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.Therapeutic Advances in Respiratory Disease|October 28, 2022
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutationsPing-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, et al.Cancers|February 25, 2022
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKIJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.Thoracic Cancer|December 16, 2022
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancerJohn Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, et al.Pageof 12